Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

Nearly a week and a half into a trial of an alleged drug “kingpin” and two others, a federal judge in Mobile on Tuesday ...